Skip to main content
Back to homepage
Overview
Press Releases
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Coverage Analysts
SEC Filings
SEC Filings
Annual Reports & Proxies
Governance
Executive Management
Board of Directors
Committee Composition
Resources
Investor FAQs
Email Alerts
Contact
Menu
Press Releases
Overview
Press Releases
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Coverage Analysts
SEC Filings
SEC Filings
Annual Reports & Proxies
Governance
Executive Management
Board of Directors
Committee Composition
Resources
Investor FAQs
Email Alerts
Contact
Normal
Press release year list
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
June 01, 2023
ADC Therapeutics to Participate in the Jefferies Healthcare Conference
May 11, 2023
ADC Therapeutics Announces Updated Results from LOTIS-2 Trial to be Presented at the European Hematology Association 2023 Hybrid Congress
May 10, 2023
ADC Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
May 09, 2023
ADC Therapeutics Reports First Quarter 2023 Financial Results and Provides Business and Strategy Update
May 02, 2023
ADC Therapeutics to Host First Quarter 2023 Financial Results Conference Call on May 9, 2023
March 15, 2023
ADC Therapeutics Releases its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2022
March 01, 2023
ADC Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference
February 28, 2023
ADC Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
February 21, 2023
ADC Therapeutics to Host Fourth Quarter and Year-End 2022 Financial Results Conference Call on February 28, 2023
February 02, 2023
ADC Therapeutics Announces Pricing of Underwritten Offering by a Selling Shareholder
February 01, 2023
ADC Therapeutics to Participate in February Investor Conferences
January 04, 2023
ADC Therapeutics to Participate in the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
ADC Therapeutics Appoints Mohamed Zaki as Chief Medical Officer